CN108148891A - The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing - Google Patents
The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing Download PDFInfo
- Publication number
- CN108148891A CN108148891A CN201810180473.2A CN201810180473A CN108148891A CN 108148891 A CN108148891 A CN 108148891A CN 201810180473 A CN201810180473 A CN 201810180473A CN 108148891 A CN108148891 A CN 108148891A
- Authority
- CN
- China
- Prior art keywords
- dna
- pcr
- tumor cell
- probe
- capture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of probe preparation method of DNA of tumor cell injury repair related gene capture sequencing, target gene includes 58 DNA of tumor cell injury repair related genes in this method;This method includes at least following steps:Step 1:Prepare the full exon region probe of 58 HRD genes;Step 2:Capture 58 target gene DNA;Step 3:Carry out elution program;Step 4:PCR reaction systems expand after carrying out capture target dna;Step 5:After amplified production magnetic beads for purifying, quantitative to 20ng/ul with qubit, packing preserves.The probe preparation method of the present invention highly effective can be solved at present for the polygenic Acquisition Detection of the homologous recombination repairs defect such as clinically breast cancer, oophoroma, cancer of pancreas and prostate cancer for 58 gene traps with reference to high-flux sequence platform.
Description
Technical field
The mutation of homologous recombination repair dcc gene and mispairing gene repair after being damaged the present invention relates to a kind of DNA of tumor cell
The probe preparation method of the capture sequencing of defect.Genetic risk available for breast cancer, oophoroma, prostate cancer and cancer of pancreas is commented
Valency and targeted drug detection.
Background technology
The development of new-generation sequencing technology, the research for modern genetic group opens new situation, however genome is surveyed
The cost of sequence and the complexity of analysis still allow researcher to feel more difficult, and the appearance of target sequence capture technique alleviates
These problems.Target sequence capture sequencing is for the sequencing carried out after known specific gene group region design probe.It is outer aobvious
Subgroup capture sequencing is then one of special case, it is specific to the research of whole exon regions in genome.More bases
Because the sequencing of full extron is that high throughput is carried out after the full exon 1 domain dna of polygenes is captured and is enriched with using sequence capturing technology
The genome analytical method of sequencing.Since it has to common and rare variation high sensitivity, exon 1 portion big absolutely can be found
Point disease correlation variation and the advantages that the genome to about 1% is only needed to be sequenced, promotes the full extron sequencing of polygenes
As the most effective strategy of Disease-causing gene of identification such as Mendel's disease disease, it is also employed for complex disease tumor susceptibility gene
In research and clinical diagnosis.
Target sequence captures the specific fragment for referring to selectively detach or be enriched with by some way genome.From
This definition sees that the PCR of target fragment is also one kind of target sequence capture, but this method flux is small, a current PCR
Longest genomic DNA fragment is obtained no more than 50Kb, and needs special enzyme and special PCR conditions, it is expensive, surely
Qualitative difference.Another catching method is according to the probe of nucleic acid molecules base complementrity, these probes are fixed on certain supports
On, for detaching, genomic DNA is then interrupted, in addition hybridizing behind street corner with probe, is eluted as the DNA in hybridization, recycling target
DNA fragmentation can directly build library and carry out DNA sequencing.
This method experimentation is simple, inexpensive.
Invention content
The purpose of the present invention is to provide a kind of probe preparations of DNA of tumor cell injury repair related gene capture sequencing
Method, the capture probe of target gene in this method, be the target gene of biotin labeling specific probe group, the target
Gene includes following 58 DNA of tumor cell injury repair related gene:RAD50、RAD51、RAD51D、RAD51C、RAD51B、
Rad52、BRIP1、BARD1、BAP1、WRN、FANCA、FANCD2、FAM175A、CHEK2、CHEK1、ATM、ATR、BRCA1、
BRCA2、NBN、PALB2、MRE11A、XRCC3、CDK12、c11orf30、CCNE1、FANCC、FANCI、POLQ、MMS22L、
RMI2、TP53、PTEN、STK11、PI3K、TSC1、TSC2、MLH1、MSH2、MSH6、PMS2、EPCAM、POLE、JAK1、JAK2、
NF1、NOTCH1、KRAS、MDM2、MDM4、DNMT3A、B2M、TS、ERCC2、ERCC6、MSH4、FANCM、CEP164;This method
Including at least following steps:
Step 1:Prepare the full exon region probe of 58 HRD genes;
Step 2:Capture 58 target gene DNA;
Step 3:Carry out elution program;
Step 4:PCR reaction systems expand after carrying out capture target dna;
Step 5:After amplified production magnetic beads for purifying, quantitative to 20ng/ul with qubit, packing preserves.
Further, in the step 2, including at least as follows step by step:
Step 2.1:The chip of 12K difference oligonucleotides quantity is synthesized, the chip includes 200bp target areas and leads to
15 base ends:
5′-ATCGCACCAGCGTGTN120CACTGCGGCTCCTCA-3′;
Step 2.2:The oligonucleotide library of synthesis is dissolved in the low concentration TE solution of 500ul;
Step 2.3:A concentration of fmol ranks of each oligonucleotides, amplification obtain required concentration;
Step 2.4:PCR product is run with 5% glue, the PCR product of 230bp sizes is then recycled, is dissolved into 100ul water;
Step 2.5:Solution company is carried out by PCR, obtains the single-stranded oligonucleotide fragment with biotin.
Further, in the step 2.3,
Primer sequence is specially:
A 5′Biotin-CTGGGAATCGCACCAGCGTGT-3′
B 5′-CGTGGATGAGGAGCCGCAGTG-3′。
Further, in the step 2.3, amplification condition is:Prepare 3 50ul PCR reaction systems, template difference
For 1ul, 2ul, 5ul;
PCR reaction conditions:95℃5min;95℃30S;60℃2min.
Further, in the step 3, including at least as follows step by step:
Step 3.1:Prepare following mixed liquor:The Adaptor Block and 6ul of 4ul 500ng DNA libraries, 2ul 200uM
capture probe;
Step 3.2:In PCR instrument, 95 DEG C of 5min, 60 DEG C of 5min;
Step 3.3:Add in the 2X hybridization solutions of 60 DEG C of preheatings of 10ul;
Step 3.4:Hybridize for 24 hours for 60 DEG C in PCR instrument.
The solution have the advantages that:The probe preparation method of the present invention is measured for 58 gene traps with reference to high pass
Sequence platform highly effective can solve homologous heavy for clinically breast cancer, oophoroma, cancer of pancreas and prostate cancer etc. at present
Group repairs the polygenic Acquisition Detection of defect.
Specific embodiment
The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing, this method include the following steps:
(1) total DNA in normal blood is extracted, extracts and interrupts DNA;
(2) end-filling, 3 ends add " A ";
(3) connector is connected and is purified;
(4) Pre-PCR is reacted and is purified;
(5) enriched DNA fragments probe hybridizes;
(6) magnetic capture target area domain dna;
(7) Pro-PCR is reacted and is purified.
The method that step (1) interrupts DNA is:
1. the genomic DNA of preparation is transferred to 0.6mL Maxy Clear Snaplock according to more than system
In Microcentrifuge Tube, abundant mixing, of short duration centrifugation is placed on for use on ice;
2. opening ultrasound in advance interrupts instrument Bioruptor Pico, after SAPMAC method instrument temperature is down to 4 DEG C, arrange parameter ON
30s, OFF 30s are 1 cycle, are a wheel per 10cycles, carry out 3 wheels altogether, sample is placed on oscillator after every group
Abundant mixing carries out next round and interrupts (mixing is more abundant, interrupts sample fragment size and more concentrates) after of short duration centrifugation;
3. 1 μ l samples is taken to carry out segment detection using Agilent2100 (DNA 1000Assay), rear sample is normally interrupted
Main peak is detected about in 150bp-200bp.
Step (2) end-filling, 3 ends add the method for " A " to be:
1. in the sample cell after interrupting, by following table configuration reaction system (this operation carries out on ice chest):
Component | Amount |
The double chain DNA fragment interrupted | 50μl |
End Repair&A-Tailing buffer solutions | 7μl |
End Repair&A-Tailing Enzyme Mix | 3μl |
Total volume | 60μl |
2. brief concussion centrifugation, PCR pipe is put back on ice chest, carries out lower step experiment immediately;
3. running PCR instrument program, PCR instrument parameter is set.Hot 85 DEG C of lid temperature setting;Heating module sets 20 DEG C, the time
30min;65 DEG C, time 30min;4℃∞;
4. PCR pipe is put into PCR instrument, program is run;Lower step coupled reaction is carried out immediately after the completion of program operation.
Simultaneously purification process is for the connector connection of step (3);
1. adapter is diluted to suitable concentration by according to the form below in advance:
DNA50 microlitres of total amount of segment | Adapter stock concentration | Connector:Target gene ratio |
500ng | 15μM | 20:1 |
2. in the PCR pipe of above-mentioned step2 reactions, by following table configuration reaction system, (this operation is enterprising in ice chest
Row):
Component | Volume |
The sample terminated from step2 reactions | 60μl |
Connector (concentration as required) | 5μl |
Seedless sour water | 5μl |
Connect buffer solution | 30μl |
DNA ligase | 10μl |
Total volume | 110μl |
3. gently inhaling and beating mixing 6 times, avoid generating bubble, then of short duration centrifugation;
4. running PCR instrument program (it is required that being covered without heat), PCR instrument parameter is set, heating module sets 20 DEG C, time 15min.
PCR pipe is put into PCR instrument, runs program;
It is 5. Agencourt AMPure XP magnetic beads is uniformly mixed spare by being shaken in advance to room temperature;
6. it in the PCR pipe carried out in step3 steps, is tested according to the purifying magnetic bead of 0.8X volumes, by following table
Lattice configuration reaction system (this operation carries out on ice chest):110 μ l of sample:Agencourt AMPure XP beads 88μl;
7. it gently inhales and beats mixing 6 times;
5-15min is incubated 8. being stored at room temperature, PCR pipe is placed in 3min on magnetic frame;
9. removing supernatant, PCR pipe continues to be placed on magnetic frame, and 200 μ l, 80% ethanol solutions are added in into PCR pipe, quiet
Put 30s;
10. removing supernatant, then 200 μ l, 80% ethanol solutions are added in into PCR pipe, supernatant is thoroughly removed after standing 30s
(removing bottom residual ethanol solution using 10 μ l pipettors);
11. being stored at room temperature 3-5min, residual ethanol is made thoroughly to volatilize;
12. adding in the Nuclease free water of 22 μ l, PCR pipe from magnetic frame is removed, gently inhales and beats resuspension magnetic
Pearl avoids generating bubble, is stored at room temperature 2min;
13. PCR pipe is placed in 2min on magnetic frame;
14. drawing 20 μ l supernatants with pipettor, it is transferred in new PCR pipe and (is placed on ice chest), in reaction tube subscript
Remember sample number, prepare to react in next step.
The Pre-PCR reactions of step (4) and purification process:
1. in the pipe of step4 steps 10, by following table lattice configuration reaction system (this operation carries out on ice chest):
Component | Quantity |
Sample from step4 steps 10 | 20μl |
KAPA HiFi HotStart ReadyMix(2X) | 25μl |
PE1.0(10μM) | 2.5μl |
PE2.0-indexX(10μM) | 2.5μl |
Total amount | 50μl |
2. mixing is gently blown using pipettor, then of short duration centrifugation;
3. sample is placed in PCR instrument, start PCR programs, it is as follows:
4. the purifying of magnetic bead is carried out after the completion of program operation immediately.
5. adding in 50 μ l Agencourt AMPure XP magnetic beads into the PCR pipe after the reaction of step5, blown with pipettor
Mixing is beaten, avoids generating bubble;
6. being incubated at room temperature 5-15min, PCR pipe is placed in 3min on magnetic frame;
7. removing supernatant, PCR pipe continues to be placed on magnetic frame, and 200 μ l, 80% ethanol solutions are added in into PCR pipe, quiet
Put 30s;
8. removing supernatant, then 200 μ l, 80% ethanol solutions are added in into PCR pipe, thoroughly removing supernatant after standing 30s (makes
Bottom residual ethanol solution is removed with 10 μ l pipettors);
9. being stored at room temperature 5min, residual ethanol is made thoroughly to volatilize;
10. adding in the Nuclease free water of 30ul, centrifuge tube is removed from magnetic frame, using pipettor, gently
Suction, which is beaten, is resuspended magnetic bead;
11. being stored at room temperature 2min, 200 μ l PCR pipes are placed in 2min on magnetic frame;
It (is placed on ice chest) 12. supernatant is transferred in 200 new μ l PCR pipes with pipettor, is marked on reaction tube
Good catalogue number(Cat.No.) prepares to react in next step;
13. 1 μ l samples is taken to use3.0 Fluorometer (Qubit dsDNA HS Assay Kit) are into style of writing
Library concentration mensuration records library concentration;
14. 1 μ l samples is taken to use 2100 Bioanalyzer system of Agilent (Agilent DNA 1000Kit)
Library fragments length measurment is carried out, library length is about between 220-320bp.
The enriched DNA fragments probing procedure of step (5):
1. ready sample and 58 gene trap probe mixtures are put into vacuum concentration centrifuge, PCR pipe is opened
Lid starts centrifuge, opens vacuum pump switch, starts concentration (when can first be concentrated before concentration with the water of same volume
Between test, calculate sample unit volume reduction time, confirm concentration speed, avoid when carrying out sample concentration, because concentrate when
Between it is long cause over-drying, sample is caused to be lost);
2. the sample drained is dissolved in again in 9 μ l Nuclease-free water, about 10 μ l of total volume, gently inhales and beat
Mixing, of short duration centrifugation are placed on for use on ice;
3. 58 gene trap probe buffer solutions are placed in room temperature to melt, precipitation is had before not heating and is occurred, mixing postposition
It is preheated in 65 DEG C of water-baths, (no precipitation and muddy object) takes 20 μ l, 58 gene trap probe buffer solutions after being completely dissolved;
4. being placed in 200 new μ lPCR pipes, pipe lid is covered, labeled as A, it is for use to continue to be placed in incubation in 65 DEG C of water-baths;
5. 5 μ l RNase Block and 2 μ l Probe is taken to be placed in 200 μ lPCR pipes, gently inhale and play mixing, of short duration centrifugation
Be placed on it is for use on ice, labeled as C;
6. PCR instrument parameter is set, 100 DEG C of heat lid, 95 DEG C, 5min;65 DEG C, hold;
7. PCR pipe B is placed in PCR instrument, procedure above is run;
When 8.PCR instrument temperature is down to 65 DEG C, PCR pipe A is placed in PCR instrument and is incubated, cover PCR instrument heat lid;
9. after 5min, C being placed on PCR and is incubated, PCR instrument heat lid is covered;
10. after PCR pipe C is placed into PCR instrument 2min, pipettor is adjusted to 13 μ l, 13 μ l Hyb are drawn from PCR pipe A
Buffer solution is moved in PCR pipe C, draws sample in whole PCR pipe B;
11. moving in PCR pipe C, gently inhale and make a call to 10 times, abundant mixing avoids generating a large amount of bubbles, and seal pipe lid covers
PCR instrument heat lid, 65 DEG C are incubated overnight (16-24h).
The method of step (6) magnetic capture target area domain dna:
1. magnetic bead (Dynabeads MyOne Streptavidin T1magnetic beads) is vortexed from 4 DEG C of taking-ups
Concussion is resuspended;
2. 50 μ l magnetic beads is taken to be placed in new PCR pipe, 1min on magnetic frame is placed in, removes supernatant;
3. removing PCR pipe from magnetic frame, 200 μ L Binding Buffer of addition, which gently inhale, beats mixing for several times, and magnetic is resuspended
Pearl;
4. putting 1min on magnetic frame, supernatant is removed;
5. repeating step 3-4 twice, magnetic bead is cleaned altogether 3 times;
6. remove PCR pipe from magnetic frame, add in 200 μ L Binding Buffer and gently inhale and make a call to 6 resuspension magnetic beads and treat
With;
7. hybrid product PCR pipe C is kept in PCR instrument, 200 μ L MyOne after the 6th step in step Step8 is resuspended
T1magnetic beads are added in the product PCR pipe C after hybridization, are made a call to 6 mixings with pipettor suction, are placed in rotation blending instrument
Upper room temperature combination 30min;
8. PCR pipe is placed in 2min on magnetic frame, supernatant is removed;
9. adding in the Wash Buffer 1 of 200 μ L into PCR pipe C, gently inhale and make a call to 6 mixings, be placed on rotation blending instrument
15min is cleaned, PCR pipe is put in 2min on magnetic frame, removes supernatant by then of short duration centrifugation;
10. adding in the Wash Buffer 2 of 65 DEG C of preheatings of 200 μ l, vortex mixing 5s is placed in ThermoMixer upper 65
DEG C 10min is incubated, 800 turns/min of rotating speed cleaned;
11. PCR pipe is put in 2min on magnetic frame, removes supernatant by of short duration centrifugation.Repetition is washed 2 times and is cleaned, 3 times altogether.Most
It is primary afterwards thoroughly to remove except Wash Buffer2 (be removed with 10 μ l pipettors and be remained);
12.PCR pipes continue to be placed on magnetic frame, and 200 μ l, 80% ethyl alcohol is added in into PCR pipe, are thoroughly moved after standing 30s
Except ethanol solution (can be removed with 10 μ l pipettors and be remained), room temperature dries 2min;
13. adding in 30 μ L Nuclease-free water to PCR pipe, PCR pipe is removed from magnetic frame, gently inhales and makes a call to 6
Secondary resuspension magnetic bead is for use.
The method that step (7) Pro-PCR is reacted and purified:
1. needing to be enriched with DNA library after capture, Mix is prepared according to following table:
Component | Each sample volume |
Sample from step9 steps 7 | 30μl |
Post PCR Buffer | 18μl |
Post PCR Primer(25μM) | 1μl |
Post DNA Polymerase | 1μl |
Total volume | 50μl |
2. pipettor is adjusted to 40 μ l, gently inhales and beat mixing 6 times, be subsequently placed in PCR instrument;
3. run PCR instrument program:
4.PCR terminates backward sample and adds in 55 μ l Agencourt AMPure XP magnetic beads, is gently inhaled and made a call to 6 times with pipettor
Mixing;
5. being incubated at room temperature 5min, PCR pipe is placed in 3min on magnetic frame;
6. removing supernatant, PCR pipe continues to be placed on magnetic frame, adds in 200 μ l, 80% absolute ethyl alcohols, stands 30s;
7. removing supernatant, then 200 μ l, 80% absolute ethyl alcohols are added in into PCR pipe, thoroughly removing supernatant after standing 30 (can
Bottom residual alcohol is removed with 10 μ l pipettors);
8. it is placed at room temperature for 5min so that residual ethanol is thoroughly volatilized;
9. adding in 25 μ l Nuclease-free water, PCR pipe from magnetic frame is taken down, gently blows and beats mixing and magnetic is resuspended
Pearl is placed at room temperature for 2min;
10. PCR pipe is placed in 2min on magnetic frame;
11. inhaling 23 μ l supernatants with pipettor is transferred to 1.5ml centrifuge tubes, sample message is marked;
12. 1 μ l libraries is taken to be quantified using Qubit dsDNA HS Assay Kit, library concentration is recorded, library is dense
Degree is about in 1-10ng/ μ l;
13. take 1 μ l samples using Agilent 2100Bioanalyzer system (Agilent DNA 1000Kit) into
Library fragment length of composing a piece of writing measures, and library length is about between 220-320bp;
14. it is sequenced using high-flux sequence platform.
Claims (5)
1. the probe preparation method of DNA of tumor cell injury repair related gene capture sequencing, it is characterised in that:Mesh in this method
The capture probe of gene is marked, is the specific probe group of the target gene of biotin labeling, the target gene includes following 58
A DNA of tumor cell injury repair related gene:RAD50、RAD51、RAD51D、RAD51C、RAD51B、Rad52、BRIP1、
BARD1、BAP1、WRN、FANCA、FANCD2、FAM175A、CHEK2、CHEK1、ATM、ATR、BRCA1、BRCA2、NBN、
PALB2、MRE11A、XRCC3、CDK12、c11orf30、CCNE1、FANCC、FANCI、POLQ、MMS22L、RMI2、TP53、
PTEN、STK11、PI3K、TSC1、TSC2、MLH1、MSH2、MSH6、PMS2、EPCAM、POLE、JAK1、JAK2、NF1、
NOTCH1、KRAS、MDM2、MDM4、DNMT3A、B2M、TS、ERCC2、ERCC6、MSH4、FANCM、CEP164;This method is at least
Include the following steps:
Step 1:Prepare the full exon region probe of 58 HRD genes;
Step 2:Capture 58 target gene DNA;
Step 3:Carry out elution program;
Step 4:PCR reaction systems expand after carrying out capture target dna;
Step 5:After amplified production magnetic beads for purifying, quantitative to 20ng/ul with qubit, packing preserves.
2. the probe preparation method of DNA of tumor cell injury repair related gene capture sequencing according to claim 1,
It is characterized in that:In the step 2, including at least as follows step by step:
Step 2.1:The chip of 12K difference oligonucleotides quantity is synthesized, the chip includes 200bp target areas and general
15 base ends:
5′-ATCGCACCAGCGTGTN120CACTGCGGCTCCTCA-3′;
Step 2.2:The oligonucleotide library of synthesis is dissolved in the low concentration TE solution of 500ul;
Step 2.3:A concentration of fmol ranks of each oligonucleotides, amplification obtain required concentration;
Step 2.4:PCR product is run with 5% glue, the PCR product of 230bp sizes is then recycled, is dissolved into 100ul water;
Step 2.5:Solution company is carried out by PCR, obtains the single-stranded oligonucleotide fragment with biotin.
3. the probe preparation method of DNA of tumor cell injury repair related gene capture sequencing according to claim 2,
It is characterized in that:In the step 2.3,
Primer sequence is specially:
A 5′Biotin-CTGGGAATCGCACCAGCGTGT-3′
B 5′-CGTGGATGAGGAGCCGCAGTG-3′。
4. the probe preparation method of DNA of tumor cell injury repair related gene capture sequencing according to claim 2,
It is characterized in that:In the step 2.3, amplification condition is:3 50ul PCR reaction systems are prepared, template is respectively 1ul,
2ul, 5ul;
PCR reaction conditions:95℃5min;95℃30S;60℃2min.
5. the probe preparation method of DNA of tumor cell injury repair related gene capture sequencing according to claim 1,
It is characterized in that:In the step 3, including at least as follows step by step:
Step 3.1:Prepare following mixed liquor:The Adaptor Block and 6ul of 4ul 500ng DNA libraries, 2ul 200uM
capture probe;
Step 3.2:In PCR instrument, 95 DEG C of 5min, 60 DEG C of 5min;
Step 3.3:Add in the 2X hybridization solutions of 60 DEG C of preheatings of 10ul;
Step 3.4:Hybridize for 24 hours for 60 DEG C in PCR instrument.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810180473.2A CN108148891A (en) | 2018-03-05 | 2018-03-05 | The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810180473.2A CN108148891A (en) | 2018-03-05 | 2018-03-05 | The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108148891A true CN108148891A (en) | 2018-06-12 |
Family
ID=62456432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810180473.2A Pending CN108148891A (en) | 2018-03-05 | 2018-03-05 | The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108148891A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234393A (en) * | 2018-09-30 | 2019-01-18 | 上海交通大学医学院附属仁济医院 | It is a kind of for detecting the gene probe composition and kit of metastatic castration-resistant prostate cancer |
CN110079602A (en) * | 2019-05-29 | 2019-08-02 | 重庆市肿瘤研究所 | The pernicious risk assessment related gene capture probe of thyroid nodule and preparation method |
CN110373469A (en) * | 2019-08-02 | 2019-10-25 | 重庆大学附属肿瘤医院 | A kind of capture sequencing probe of carcinoma of endometrium personalized medicine and preparation method thereof |
CN110846416A (en) * | 2019-12-06 | 2020-02-28 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA non-homologous end connection repair pathway |
CN110863035A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA direct repair pathway |
CN110863048A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA homologous recombination repair pathway |
CN110863049A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA mismatch repair pathway |
CN111748622A (en) * | 2020-05-22 | 2020-10-09 | 湖南光琇高新生命科技有限公司 | Kit for detecting genetic tumor susceptibility gene and probe thereof |
CN112359096A (en) * | 2019-12-06 | 2021-02-12 | 苏州卫生职业技术学院 | Kit for detecting key mutant gene of DNA base excision repair pathway |
CN112359116A (en) * | 2019-12-06 | 2021-02-12 | 苏州卫生职业技术学院 | Kit for detecting DNA (deoxyribonucleic acid) cross-damage synthesis repair pathway key mutant gene |
CN112375820A (en) * | 2019-12-06 | 2021-02-19 | 苏州卫生职业技术学院 | Kit for detecting key mutant gene of DNA nucleotide excision repair pathway |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050037362A1 (en) * | 2003-08-11 | 2005-02-17 | Eppendorf Array Technologies, S.A. | Detection and quantification of siRNA on microarrays |
US20110177975A1 (en) * | 1996-02-09 | 2011-07-21 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
CN104789687A (en) * | 2015-05-08 | 2015-07-22 | 上海允英医疗科技有限公司 | Probe preparation method for multi-gene capture sequencing |
CN104818336A (en) * | 2015-05-13 | 2015-08-05 | 广州燃石医学检验所有限公司 | Method for enriching gene 56 target region based on multiple probes |
CN106047998A (en) * | 2016-05-27 | 2016-10-26 | 深圳市海普洛斯生物科技有限公司 | Detection method and application of lung cancer genes |
US20170081724A1 (en) * | 2014-03-19 | 2017-03-23 | Dana-Farber Cancer Institute, Inc. | Method and kits for determining sensitivity to cancer treatment |
CN107236727A (en) * | 2017-05-31 | 2017-10-10 | 江苏为真生物医药技术股份有限公司 | The single-stranded probe preparation method of polygenes capture sequencing |
-
2018
- 2018-03-05 CN CN201810180473.2A patent/CN108148891A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110177975A1 (en) * | 1996-02-09 | 2011-07-21 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US20050037362A1 (en) * | 2003-08-11 | 2005-02-17 | Eppendorf Array Technologies, S.A. | Detection and quantification of siRNA on microarrays |
US20170081724A1 (en) * | 2014-03-19 | 2017-03-23 | Dana-Farber Cancer Institute, Inc. | Method and kits for determining sensitivity to cancer treatment |
CN104789687A (en) * | 2015-05-08 | 2015-07-22 | 上海允英医疗科技有限公司 | Probe preparation method for multi-gene capture sequencing |
CN104818336A (en) * | 2015-05-13 | 2015-08-05 | 广州燃石医学检验所有限公司 | Method for enriching gene 56 target region based on multiple probes |
CN106047998A (en) * | 2016-05-27 | 2016-10-26 | 深圳市海普洛斯生物科技有限公司 | Detection method and application of lung cancer genes |
CN107236727A (en) * | 2017-05-31 | 2017-10-10 | 江苏为真生物医药技术股份有限公司 | The single-stranded probe preparation method of polygenes capture sequencing |
Non-Patent Citations (24)
Title |
---|
冯湘君等: "人胰腺癌细胞中对5-氟尿嘧啶耐药相关基因的检测分析", 《南京医科大学学报》 * |
吴霞等: "应用第2代测序技术检测高级别卵巢浆液性腺癌患者BRCA1/2基因的突变", 《中华妇产科杂志》 * |
孔阳阳等: "BTR复合物在DNA损伤修复中的研究进展", 《生命科学》 * |
张仁峰等: "p53基因与肿瘤治疗研究进展", 《现代免疫学》 * |
李学孝等: "DNA聚合酶θ与肿瘤关系的研究进展", 《中国普通外科杂志》 * |
杨付花: "慢性髓细胞白血病、星形细胞瘤的克隆演化研究", 《中国优秀博士学位论文全文数据库》 * |
段瑞等: "外周T细胞淋巴瘤分子病理学研究进展", 《诊断病理学杂志》 * |
沙亚哈提.别尔克哈之: "AP1等在哈萨克族食管癌组织及细胞株表观遗传调控中的表达研究", 《中国优秀硕士学位论文全文数据库》 * |
牛春雨等: "《病理生理学》", 28 February 2013 * |
王志刚等: "DNA甲基转移酶分类、功能及其研究进展", 《遗传》 * |
王敏: "子宫内膜癌中TSC2基因启动子区甲基化状态的初步研究", 《中国优秀硕士学位论文全文数据库》 * |
王春花等: "Cep164基因在小鼠胚胎生长发育过程中的功能及作用", 《中国优秀博士学位论文全文数据库》 * |
王淑芳等: "结直肠癌风险评估模型的研究进展", 《解放军医学院学报》 * |
胥晓飞等: "端粒稳态和DNA损伤修复基因FAM175A、TLK1与早发性卵巢功能不全相关性研究", 《中国优秀博士学位论文全文数据库》 * |
范伟等主编: "《消化系癌实用基础与临床》", 31 August 2007 * |
董隽等: "DNA双链断裂与同源重组修复的研究进展", 《中国医学创新》 * |
蒋荣娜等: "小鼠骨骼肌干细胞蛋白标志JAK的发现", 《中国老年学杂志》 * |
郭力生主编: "《防原医学》", 31 December 2006 * |
郭建宾等: "抗PD-1/PD-L1免疫治疗在子宫内膜癌中的研究和应用", 《癌症进展》 * |
郭紫薇等: "表皮生长因子受体野生型晚期非小细胞肺癌治疗的选择", 《中国全科医学》 * |
陈月沙等: "口腔癌变组织中BAP1蛋白的表达研究", 《全科口腔医学杂志》 * |
陈默等: "杜仲预防 UVB 致人成纤维细胞光老化的作用及基因水平的机制探讨", 《日用化学工业》 * |
韦青等: "遗传性消化道肿瘤现状及二代测序应用前景", 《中国医学前沿杂志(电子版)》 * |
高继英等: "错配修复基因在消化道肿瘤中作用的研究进展", 《中国临床研究》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234393A (en) * | 2018-09-30 | 2019-01-18 | 上海交通大学医学院附属仁济医院 | It is a kind of for detecting the gene probe composition and kit of metastatic castration-resistant prostate cancer |
CN110079602A (en) * | 2019-05-29 | 2019-08-02 | 重庆市肿瘤研究所 | The pernicious risk assessment related gene capture probe of thyroid nodule and preparation method |
CN110373469A (en) * | 2019-08-02 | 2019-10-25 | 重庆大学附属肿瘤医院 | A kind of capture sequencing probe of carcinoma of endometrium personalized medicine and preparation method thereof |
CN110846416A (en) * | 2019-12-06 | 2020-02-28 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA non-homologous end connection repair pathway |
CN110863035A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA direct repair pathway |
CN110863048A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA homologous recombination repair pathway |
CN110863049A (en) * | 2019-12-06 | 2020-03-06 | 苏州卫生职业技术学院 | Probe library, detection method and kit for detecting effectiveness of DNA mismatch repair pathway |
CN112359096A (en) * | 2019-12-06 | 2021-02-12 | 苏州卫生职业技术学院 | Kit for detecting key mutant gene of DNA base excision repair pathway |
CN112359116A (en) * | 2019-12-06 | 2021-02-12 | 苏州卫生职业技术学院 | Kit for detecting DNA (deoxyribonucleic acid) cross-damage synthesis repair pathway key mutant gene |
CN112375820A (en) * | 2019-12-06 | 2021-02-19 | 苏州卫生职业技术学院 | Kit for detecting key mutant gene of DNA nucleotide excision repair pathway |
CN111748622A (en) * | 2020-05-22 | 2020-10-09 | 湖南光琇高新生命科技有限公司 | Kit for detecting genetic tumor susceptibility gene and probe thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108148891A (en) | The probe preparation method of DNA of tumor cell injury repair related gene capture sequencing | |
CN107217095B (en) | Multiple PCR primer set for human paternity test and detection method | |
CN107502654A (en) | Polygenes enrichment and detection method for solid tumor targeting medication guide | |
CN111575380B (en) | Probe library for multigene detection, hybridization kit and multigene detection method | |
CN106987905A (en) | A kind of construction method and kit in BRCA1/2 genetic tests library | |
US11261479B2 (en) | Methods and compositions for enrichment of target nucleic acids | |
WO2021169875A1 (en) | Cancer gene methylation measuring system and cancer in vitro detection method executed in same | |
WO2014164838A1 (en) | Quantification of cell-specific nucleic acid markers having a particular methylation state | |
CN107365769A (en) | A kind of kit and the application of bubbling shape primer and its composition | |
CN105734679A (en) | Preparation method of nucleic acid target sequence capture sequencing library | |
CN112662762A (en) | Probe composition for detecting 5 tumors of digestive tract | |
CN109777857A (en) | A kind of polygenic capture sequencing approach of capillary malformation associated correlation | |
CN112662763A (en) | Probe composition for detecting common amphoteric cancers | |
CN109609613A (en) | A kind of DNA methylolation target area captures sequencing approach | |
CN107236727B (en) | Preparation method of single-stranded probe for polygene capture sequencing | |
US20240002912A1 (en) | Nucleic acid enrichment and detection | |
CN112662759A (en) | Probe composition for detecting 3 lumen organ tumors | |
CN113817822B (en) | Tumor diagnosis kit based on methylation detection and application thereof | |
WO2021185275A1 (en) | Probe composition for detecting 11 cancers | |
CN114381496A (en) | In-situ hybridization probe and preparation method and application thereof | |
WO2021126367A1 (en) | Efficient methods and compositions for mulitplex target amplification pcr | |
CN111197080A (en) | Detection product for distinguishing nifedipine individualized medication type | |
CN110225979B (en) | Rolling circle amplification-based genome target region enrichment method and application thereof | |
CN112391455A (en) | Kit for homologous recombination repair defect detection | |
CN111197077A (en) | Kit for detecting medication guidance gene of nifedipine serving as antihypertensive drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180612 |
|
RJ01 | Rejection of invention patent application after publication |